On the occasion of World Hemophilia Day 2018 celebrations, we are glad to announce EIGHT, an international conference on factor VIII and the role it plays in hemostasis, organized with the unrestricted support of Kedrion Biopharma.

EIGHT 2018 attendants will debate key issues such as treatment options for inhibitors, precision medicine, and objectives for the future, first of which is to increase access to therapies.

EIGHT 2018 will take place on 12th and 13th October in Budapest, Hungary, where Kedrion this year celebrates the tenth anniversary of its direct presence.

More information on all Kedrion supported initiatives for the WHD 2018 are available here.